What was NDT Pharmaceuticals’s price range in the past 12 months?
NDT Pharmaceuticals lowest stock price was $0.02 and its highest was $2.10 in the past 12 months.
What is NDT Pharmaceuticals’s market cap?
NDT Pharmaceuticals’s market cap is $7.75M.
When is NDT Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is NDT Pharmaceuticals overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does NDT Pharmaceuticals pay dividends?
NDT Pharmaceuticals does not currently pay dividends.
What is NDT Pharmaceuticals’s EPS estimate?
NDT Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NDT Pharmaceuticals have?
NDT Pharmaceuticals has 197,204,350 shares outstanding.
Which hedge fund is a major shareholder of NDT Pharmaceuticals?
Currently, no hedge funds are holding shares in NDTP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
NDT Pharmaceuticals
NDT Pharmaceuticals Inc., a biotechnology firm situated in Vienna, Virginia, is dedicated to formulating a range of treatments for serious neurological ailments, particularly those stemming from traumatic brain injuries.